Cellectis bioresearch aims at making TALEN™ technology accessible for everybody and is, therefore, always looking for new ways to meet the needs of our valued customers.

TALEN™ NØW is off-the -shelf, ready-to-use TALEN™ mRNA designed for efficient gene knock-out at a predefined locus.

For optimized ease of use and guaranteed results we validated our TALEN™ NØW:

• on a chromosomal target sequence (First validation);
• and/or functionally (by privileged users).

Take advantage of TALEN™ NØW, a member of the TALEN™ family, the next generation tools for gene customization and gene editing.

Benefits:

NEW! Our first TALEN™ NØW, targeting the eGFP gene, is now available! Find here all information.